University of Edinburgh   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Edinburgh United Kingdom (1582)

Organization Overview

First Clinical Trial
1995
NCT00002869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Clinical Research Fellow, University of Edinburgh | Edinburgh Cancer Centre at Western General Hospital | Edinburgh Cancer Research Centre | Edinburgh Cancer Research Centre (IGMM) | Edinburgh Cancer Research Centre, The University of Edinburgh | Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR | Edinburgh Clinical Trials Unit | Edinburgh Royal Infirmary | Edinburgh University | MRC HGU University of Ediniburgh | NHS Lothian and University of Edinburgh | NHS Lothian / University of Edinburgh | Professor of Clinical Toxicology, University of Edinburgh | Professor of Experimental Nephrology, University of Edinburgh | Reader in Nephrology, University of Edinburgh | Royal College of Surgeons of Edinburgh | Royal Infirmary, Edinburgh, U.K. | Royal Infirmary of Edinburgh | Royal Infirmary of Edinburgh at Little France | Royal Infirmary of Edinburgh, NHS Lothian | Senior Lecturer, Transplant Surgery, University of Edinburgh | The University of Edinburgh | The University of Edinburgh/ NHS Lothian | University of Edinburgh | University of Edinburgh and NHS Lothian | University of Edinburgh/NHS Lothian | University of Edinburgh, Royal Infirmary of Edinburgh, UK | University of Edinburgh, Scotland | University of Edinburgh, UK | Western General Hospital | Western General Hospital, Edinburgh | Western General Hospital, Edinburgh Cancer Centre | Western General Hospital, Edinburgh, United Kingdom | Western Hospital